Didier Tchétché1, MD; Susheel K. Kodali2, MD; Danny Dvir3, MD
1. Clinique Pasteur, Toulouse, France; 2. Columbia University Irving Medical Center, New York, NY, USA; 3. Shaare Zedek Medical Center, Jerusalem, Israel
Figure 1. The Pi-Cardia ShortCut device. The ShortCut procedure: A. PA positioning; B. SE activation. The yellow circle shows splitting of the bioprosthetic leaflet facing the left main coronary artery; C. splitting; and D. good coronary flow post-split and TAVR. The arrow points to patency of the left main coronary artery at the end of the procedure. PA: positioning arm; SE: splitting element; TAVR: transcatheter aortic valve replacement
Coronary obstruction is a life-threatening complication that occurs in 2.3% of patients undergoing transcatheter aortic valve replacement (TAVR) for degenerated bioprostheses1. During a valve-in-valve (ViV) procedure, the leaflets of the prior valve ...